DCF — TRI-CITY MEDICAL CENTER
Enterprise Value: $-771.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-771.5M
Enterprise Value
$-238.3M
PV of Cash Flows
$-533.2M
PV of Terminal Value
$-858.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $311.5M | $-51.2M | -16.0% | $-64.4M | $-58.5M |
| Year 2 | $320.8M | $-49.5M | -15.0% | $-63.1M | $-52.2M |
| Year 3 | $330.4M | $-47.7M | -14.0% | $-61.7M | $-46.4M |
| Year 4 | $340.3M | $-47.4M | -14.0% | $-61.9M | $-42.2M |
| Year 5 | $350.6M | $-48.0M | -14.0% | $-62.8M | $-39.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-771.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$302.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.1694063012536338
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5